[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Report 2016

December 2016 | 103 pages | ID: U5F6D1F6AF9EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter

Revenue, means the sales value of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter

This report studies sales (consumption) of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Acrostak (Schweiz) AG
  • Concept Medical Inc
  • Lifetech Scientific
  • Micell Technologies, Inc
  • SurModics, Inc.
  • The Spectranetics Corporation
  • Vascular Nanotransfer Technologies Company
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Report 2016

1 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER OVERVIEW

1.1 Product Overview and Scope of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
1.2 Classification of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter (2011-2021)
  1.4.1 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales and Growth Rate (2011-2021)
  1.4.2 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Growth Rate (2011-2021)

2 UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER COMPETITION BY MANUFACTURERS

2.1 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Average Price by Manufactures (2015 and 2016)
2.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Competitive Situation and Trends
  2.4.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Concentration Rate
  2.4.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales and Market Share by Type (2011-2016)
3.2 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Market Share by Type (2011-2016)
3.3 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Price by Type (2011-2016)
3.4 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales and Market Share by Application (2011-2016)
4.2 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MANUFACTURERS PROFILES/ANALYSIS

5.1 Acrostak (Schweiz) AG
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Acrostak (Schweiz) AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Concept Medical Inc
  5.2.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Concept Medical Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Lifetech Scientific
  5.3.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Lifetech Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Micell Technologies, Inc
  5.4.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Micell Technologies, Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 SurModics, Inc.
  5.5.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 SurModics, Inc. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 The Spectranetics Corporation
  5.6.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 The Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Vascular Nanotransfer Technologies Company
  5.7.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Vascular Nanotransfer Technologies Company Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MANUFACTURING COST ANALYSIS

6.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MARKET FORECAST (2016-2021)

10.1 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue Forecast (2016-2021)
10.2 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Forecast by Type (2016-2021)
10.3 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Forecast by Application (2016-2021)
10.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Table Classification of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Figure United States Sales Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter by Type in 2015
Table Application of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Figure United States Sales Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter by Application in 2015
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales and Growth Rate (2011-2021)
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Growth Rate (2011-2021)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales of Key Manufacturers (2015 and 2016)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Share by Manufacturers
Figure 2016 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Share by Manufacturers
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue by Manufacturers (2015 and 2016)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue Share by Manufacturers
Table 2016 United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue Share by Manufacturers
Table United States Market Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Average Price of Key Manufacturers in 2015
Figure Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share of Top 3 Manufacturers
Figure Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share of Top 5 Manufacturers
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales by Type (2011-2016)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Share by Type (2011-2016)
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share by Type in 2015
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Market Share by Type (2011-2016)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter by Type (2011-2016)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Price by Type (2011-2016)
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Growth Rate by Type (2011-2016)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales by Application (2011-2016)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share by Application (2011-2016)
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share by Application in 2015
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Growth Rate by Application (2011-2016)
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Growth Rate by Application (2011-2016)
Table Acrostak (Schweiz) AG Basic Information List
Table Acrostak (Schweiz) AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Acrostak (Schweiz) AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share (2011-2016)
Table Concept Medical Inc Basic Information List
Table Concept Medical Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
Table Concept Medical Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share (2011-2016)
Table Lifetech Scientific Basic Information List
Table Lifetech Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lifetech Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share (2011-2016)
Table Micell Technologies, Inc Basic Information List
Table Micell Technologies, Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
Table Micell Technologies, Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share (2011-2016)
Table SurModics, Inc. Basic Information List
Table SurModics, Inc. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
Table SurModics, Inc. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share (2011-2016)
Table The Spectranetics Corporation Basic Information List
Table The Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
Table The Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share (2011-2016)
Table Vascular Nanotransfer Technologies Company Basic Information List
Table Vascular Nanotransfer Technologies Company Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vascular Nanotransfer Technologies Company Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Figure Manufacturing Process Analysis of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Figure Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Industrial Chain Analysis
Table Raw Materials Sources of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Major Manufacturers in 2015
Table Major Buyers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Table Distributors/Traders List
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production and Growth Rate Forecast (2016-2021)
Figure United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Growth Rate Forecast (2016-2021)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Forecast by Type (2016-2021)
Table United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories